Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05887622

The Potassium Supplementation Study

The Role of Potassium Supplementation on Endothelial Function, BP Regulation, and Oxidative Stress Under High Sodium Conditions

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
University of Delaware · Academic / Other
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

This study will test whether potassium supplementation can reduce the deleterious effect of a high sodium diet on blood vessel function, blood pressure reactivity and autonomic nervous system function in apparently healthy adults.

Detailed description

Excess sodium intake is linked to poor blood pressure (BP) regulation and endothelial dysfunction, both of which are implicated in the pathogenesis of atherosclerosis and high BP. Evidence suggests potassium may offset the damaging effects of sodium; however, studies in healthy adults are lacking. This is important as these pre-clinical risk factors have been observed in this population, suggesting early intervention may be critical for cardiovascular disease prevention. High potassium diets have been effective at attenuating a sodium-induced decline in endothelial function. However, potassium intake was increased using whole foods; thus, the vascular benefits cannot be attributed solely to potassium. Furthermore, whether potassium can reduce sodium-induced oxidative stress is unknown. The central hypothesis of this study is that endothelial function will be greater and BP reactivity and oxidative stress will be lower with a high potassium intake compared to a low potassium intake, in the context of a high sodium diet. The investigators will assess macrovascular function using flow-mediated dilation, BP reactivity using the cold pressor test and isometric handgrip grip test, and oxidative stress using electron paramagnetic resonance.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPotassium chloride supplementSubjects will receive 64 mmol of KCl on the high potassium/high sodium condition.
DIETARY_SUPPLEMENTPlaceboSubjects will receive a placebo capsule on the moderate potassium/low sodium diet and the moderate potassium/high sodium diet

Timeline

Start date
2022-01-24
Primary completion
2025-12-31
Completion
2026-01-31
First posted
2023-06-05
Last updated
2025-06-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05887622. Inclusion in this directory is not an endorsement.